Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
Marquette University · NCT05919745
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- October 19, 2023
- Record last updated
- September 27, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized clinical trial is to compare patient-reported pain and oral health-related quality of life during the first postoperative week following extraction and bone graft surgery in patients who received preemptive ibuprofen versus placebo. Participants will receive ibuprofen 600mg or placebo by mouth with water 1 hour prior to extraction and bone graft surgery.
The primary question it aims to answer is
- Does preemptive ibuprofen have an effect on postoperative pain 1 hour following extraction and bone graft surgery compared to placebo?
Secondary questions are
- Does preemptive ibuprofen have an effect on pain during the first 3 postoperative hours and 7 postoperative days following extraction and bone graft surgery compared to placebo?
- Does preemptive ibuprofen have an effect on oral health-related quality of life during the 7 postoperative days following extraction and bone graft surgery compared to placebo?
Being studied: Ibuprofen 600 mg; Placebo; Acetaminophen
Conditions: Pain, Post Operative; Quality of Life
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age >18 years
- Good general health (controlled conditions)
- Fluent in English
- Treatment-planned for single site extraction and bone graft surgery
Exclusion criteria
- Pregnancy
- Site with active infection i.e purulence, abscess formation
- Patients experiencing pain pre-operatively
- Oral surgery in more than one site/quadrant in the same session
- Patients receiving surgery under sedation
- Patients with any contraindication for oral bone grafting surgery (e.g., on anticoagulants, medication-related osteonecrosis of the jaw, etc.)
- Patients experiencing acute or chronic oral pain due to conditions or previous interventions
- Patients with diseases or taking medications that affect hard and soft tissue wound healing such as poorly controlled diabetes, bisphosphonate use, corticosteroid use, chemotherapy, immunosuppressive therapy, etc.
- Current or chronic (≥4 weeks) use of anti-inflammatory, analgesic, corticosteroid or sedative medications in the past 6 months
- Health conditions that contraindicate the use of NSAIDs, such as stomach ulcers, bleeding disorders, renal disfunction, liver cirrhosis or acute liver disease, etc.
- Intake of medications that interact with NSAIDs or whose actions can be affected by NSAIDs, such as anticoagulant/antiplatelet medications, ACE inhibitors, diuretics, etc.
- Allergy to ibuprofen, acetaminophen and/or aspirin, and study materials (e.g., sutures, grafts, membranes?).
- Patients having 3 or more alcoholic beverages daily
- Patients who are planned to undergo heart surgery or had heart surgery less than 6 months prior
- Not fluent in English
Recruiting US locations
Marquette University School of Dentistry Graduate Periodontics Clinic
Milwaukee, WI 53233
Site contact: Vrisiis Kofina, DDS, MS · 4142886521 · vrisiis.kofina@marquette.edu
Study contacts (from the official record)
- Vrisiis Kofina, DDS, MS · 516-817-0393 · vrisiis.kofina@marquette.edu
- Christos Gousias, DDS · 414-229-8875 · christos.gousias@marquette.edu
Similar studies in Wisconsin
All healthy volunteers studies in Wisconsin →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How ASP3082 is Processed in Healthy Men
Astellas Pharma Global Development, Inc.
- Location
- Madison, WI
- Eligibility basics
- Ages 18–65 · Men only
- RecruitingHealthy volunteersPhase 1
A Trial of Lu AH69593 in Healthy Participants
H. Lundbeck A/S
- Location
- Madison, WI
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- La Crosse, WI + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants
Astria Therapeutics, Inc.
- Location
- Madison, WI + 2 other US sites
- Eligibility basics
- Ages 18–55